PATENT CLAIM ANALYSIS

Application Number: 16008991
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["536", "024500"]

Abstract:
The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.

Claim (Index 16):
The method of  claim 12 , further comprising administering an effective amount of an aminobisphosphonate drug to the subject.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 94.0
- Lexical Diversity: 1.15625
- Patent Class: 536.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15706481', '15652080', '15849062', '15904131', '15668223']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7327881098349357
- 35 USC 102 Novelty (BERT): 0.630996815024296
- Combined Prediction Score: 0.7226089803538718
- Mean Citation Score: 655.757314
- Max Citation Score: 760.28394
- Similarity Product: 526.9473422778798

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test